Earnings Summary

SOLID BIOSCIENCES INC’s revenue jumped 71.65% since last year same period to $6.17Mn in the Q2 2022. On a quarterly growth basis, SOLID BIOSCIENCES INC has generated 220.47% jump in its revenue since last 3-months.

SOLID BIOSCIENCES INC’s net profit fell -34.22% since last year same period to $-25.09Mn in the Q2 2022. On a quarterly growth basis, SOLID BIOSCIENCES INC has generated 0.93% jump in its net profits since last 3-months.

SOLID BIOSCIENCES INC’s net profit margin jumped 21.81% since last year same period to -406.74% in the Q2 2022. On a quarterly growth basis, SOLID BIOSCIENCES INC has generated 69.09% jump in its net profit margins since last 3-months.

SOLID BIOSCIENCES INC’s earning per share (EPS) estimates for the current quarter stand at -1.65 - a 38.2% jump from last quarter’s estimates.

SOLID BIOSCIENCES INC’s earning per share (EPS) estimates for the current year stand at -1.65.

SOLID BIOSCIENCES INC’s earning per share (EPS) fell -12.92% since last year same period to -2.71 in the Q3 2022. This indicates that the SOLID BIOSCIENCES INC has generated -12.92% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. SOLID BIOSCIENCES INC’s return on assets (ROA) stands at -0.26.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. SOLID BIOSCIENCES INC’s return on equity (ROE) stands at -0.49.